Early treatment with plasma extracted from recovered individuals reduces the need for hospitalization by more than 50%, according to a new nationwide clinical trial.
It’s easy to become overwhelmed or confused by the contradictory messages.
The vaccine is about 50-55% effective in preventing symptomatic COVID-19 after the first dose.
Drs. Deborah Birx and Robert Redfield emphasize need for increased testing.
Answers you need now.
It’s all about “flattening the curve.”